BACKGROUND: The etiologic agent of Chagas Disease is Trypanosoma cruzi. Acute infection results in patent parasitemia and polyclonal lymphocyte activation. Polyclonal B cell activation associated with hypergammaglobulinemia and delayed specific humoral immunity has been reported during T. cruzi infection in experimental mouse models. Based on preliminary data from our laboratory we hypothesized that variances in susceptibility to T. cruzi infections in murine strains is related to differences in the ability to mount parasite-specific humoral responses rather than polyclonal B cell activation during acute infection.\ud \ud METHODOLOGY/PRINCIPAL FINDINGS: Relatively susceptible Balb/c and resistant C57Bl/6 mice were inoculated with doses of p...
Although metacyclic and blood trypomastigotes are completely functional in relation to parasite-host...
Chagas’ disease outcomes depend on several factors including parasite and host genetics, immune resp...
To study the influence of normal associated microbiota on systemic immunological responses during e...
Background: The etiologic agent of Chagas Disease is Trypanosoma cruzi. Acute infection results in p...
The etiologic agent of Chagas' disease is Trypanosoma cruzi. Patent parasitemia leads to parasite sp...
Chagas disease (ChD) is a chronic infection caused by Trypanosoma cruzi. This highly diverse intrace...
Trypanosoma cruzi is the etiologic agent of Chagas’ disease, which affects 6–7 million people worldw...
Strains of Trypanosoma cruzi are multiclonal populations that can be classified in groups or genotyp...
Trypanosoma cruzi infection in BALB/c mice induced a reversible polyisotypic hypergammaglobulinaemia...
Chagas disease, caused by the parasite Trypanosoma cruzi, is endemic in Latin America but has become...
Although metacyclic and blood trypomastigotes are completely functional in relation to parasite-host...
C3H/He and C57B1/6 mice were inoculated with 500 Trypanosoma cruzi trypomastigotes (Strain Y). Durin...
Host resistance to Trypanosoma cruzi is dependent on both natural and acquired immune responses. Dur...
Inoculation of Trypanosoma cruzi, Tulahuén strain, into C57BL/6 and BALB/c mice led to an acute infe...
Although metacyclic and blood trypomastigotes are completely functional in relation to parasite-host...
Although metacyclic and blood trypomastigotes are completely functional in relation to parasite-host...
Chagas’ disease outcomes depend on several factors including parasite and host genetics, immune resp...
To study the influence of normal associated microbiota on systemic immunological responses during e...
Background: The etiologic agent of Chagas Disease is Trypanosoma cruzi. Acute infection results in p...
The etiologic agent of Chagas' disease is Trypanosoma cruzi. Patent parasitemia leads to parasite sp...
Chagas disease (ChD) is a chronic infection caused by Trypanosoma cruzi. This highly diverse intrace...
Trypanosoma cruzi is the etiologic agent of Chagas’ disease, which affects 6–7 million people worldw...
Strains of Trypanosoma cruzi are multiclonal populations that can be classified in groups or genotyp...
Trypanosoma cruzi infection in BALB/c mice induced a reversible polyisotypic hypergammaglobulinaemia...
Chagas disease, caused by the parasite Trypanosoma cruzi, is endemic in Latin America but has become...
Although metacyclic and blood trypomastigotes are completely functional in relation to parasite-host...
C3H/He and C57B1/6 mice were inoculated with 500 Trypanosoma cruzi trypomastigotes (Strain Y). Durin...
Host resistance to Trypanosoma cruzi is dependent on both natural and acquired immune responses. Dur...
Inoculation of Trypanosoma cruzi, Tulahuén strain, into C57BL/6 and BALB/c mice led to an acute infe...
Although metacyclic and blood trypomastigotes are completely functional in relation to parasite-host...
Although metacyclic and blood trypomastigotes are completely functional in relation to parasite-host...
Chagas’ disease outcomes depend on several factors including parasite and host genetics, immune resp...
To study the influence of normal associated microbiota on systemic immunological responses during e...